FIELD: medicine, pharmacy. SUBSTANCE: invention claims a pharmaceutical composition containing acceptable carrier and physical mixture of derivatives of cyclodextrin sulfoalkyl ether and therapeutically effective amount of therapeutic agent. At least 50% of therapeutic agent does not form a complex with derivative of cyclodextrin sulfoalkyl ether of the formula (I): where n = 4, 5 or 6; each of R1,R2,R3,R4,R5,R6,R7,R8 и R9, means independently each of other -O- or -O-(C2-C6--alkylene)-SO3- where at least one of R1 and R2 means independently each of other -O-(C2-C6alkylene)-SO3-. Each of S1-S9 means independently pharmaceutically acceptable cation. Invention claims a method of preparing pharmaceutical medicinal form containing compound of the formula (I). Method involves preparing firstly solid core containing the above indicated physical mixture, pharmaceutical carrier followed by application of film coat containing film-forming agent and pore-forming agent on the core. Invention claims a pharmaceutical preparation obtained by method to be claimed. Obtained preparations exhibit increased solubility and bioavailability of an active agent. Method of their preparing does not require the preliminary preparing complexes of active components with cyclodextrin derivative. EFFECT: improved properties of agent, simplified technology of preparing. 17 cl, 20 dwg, 15 tbl, 7 ex
Authors
Dates
2001-09-10—Published
1998-04-20—Filed